Remove Data Remove Drug Development Remove healthcare technology Remove Leadership
article thumbnail

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

Exec Summary: To win the hearts and minds of the public in England and successfully deliver the NHS Federated Data Platform (FDP), Palantir should focus on the following strategies: Address Privacy Concerns: Public trust is paramount, particularly when dealing with sensitive patient data. Visit www.nelsonadvisors.co.uk

article thumbnail

Self-sovereign identity (SSI) - the future of Health Data?

Lloyd Price

Exec Summary: Self-sovereign identity (SSI) holds immense potential to revolutionize the future of health data, empowering individuals to take control of their information and fostering a more secure, transparent, and patient-centric healthcare ecosystem. This offers more control over their privacy and minimizes data oversharing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Clinical Value of Digital Phenotyping in Mental Health

Lloyd Price

Exec Summary: Digital phenotyping is a groundbreaking approach that leverages technology to gather and analyse data on individuals' behaviours, emotions, and physiological responses. In the realm of mental health, this technology holds immense potential to revolutionise diagnosis, treatment, and monitoring.

article thumbnail

Chief AI Officers in Healthcare: CAIO's emerging now with a big future ahead

Lloyd Price

Hospitals and healthcare systems are increasingly implementing AI tools for tasks like medical imaging analysis, drug discovery, and even robot-assisted surgery. With this rapid adoption, there's a need for dedicated leadership to guide responsible and strategic implementation.

article thumbnail

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

Digital Health Global

Koneksa’s digital biomarker solutions include an industry-leading platform that gives research sponsors and clinical sites the ability to seamlessly aggregate data in real-time from devices, ePROs, patient diaries, and clinical assessments to provide the full picture of an individual’s health.

article thumbnail

Taker-Shaper-Maker model and Future of Generative AI in Healthcare

Lloyd Price

Exec Summary: Generative AI is a powerful new tool with the potential to revolutionize healthcare. It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. But how can healthcare organisations best leverage this technology? Subscribe Today!

article thumbnail

Medical Record Automation: MRA emerges as one of the key HealthTech sub sectors in 2024

Lloyd Price

It's driven by a perfect storm of factors: Increasing data volumes: The sheer amount of patient data generated daily is overwhelming. Demand for efficiency: Healthcare providers are under immense pressure to reduce costs and improve patient care. Enhanced accuracy: Reduces human error in data input and retrieval.